Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40.8M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
33.5M
-
Shares change
-
+1.56M
-
Total reported value, excl. options
-
$427M
-
Value change
-
+$23.8M
-
Put/Call ratio
-
0.23
-
Number of buys
-
60
-
Number of sells
-
-47
-
Price
-
$12.75
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q4 2023
136 filings reported holding LUNG - Pulmonx Corp - COM as of Q4 2023.
Pulmonx Corp - COM (LUNG) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.5M shares
of 40.8M outstanding shares and own 82.23% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.65M shares), FMR LLC (3.31M shares), BlackRock Inc. (3.12M shares), MORGAN STANLEY (2.28M shares), VANGUARD GROUP INC (2.07M shares), Point72 Asset Management, L.P. (1.55M shares), Divisadero Street Capital Management, LP (1.41M shares), BNP Paribas Asset Management Holding S.A. (930K shares), STATE STREET CORP (875K shares), and VICTORY CAPITAL MANAGEMENT INC (854K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.